AbbVie

ABBV NYSE
65.97
-1.55
-2.30%
After Hours: 65.73 -0.24 -0.36% 19:06 08/23 EDT
Open
67.28
Prev Close
67.52
High
67.79
Low
65.48
Volume
8.91M
Avg Vol (3M)
10.61M
52 Week High
98.70
52 Week Low
62.66
% Turnover
0.60%
Market Cap
97.54B
1D
5D
1M
3M
1Y
5Y

Company Profile

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).
MORE >

Recently

Name
Price
%Change